Skip Nav Destination
Close Modal
Search Results for
cbd
Update search
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
1-20 of 46
Search Results for cbd
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
1
Sort by
Journal Articles
Michael T. Falta, Clemencia Pinilla, Douglas G. Mack, Alex N. Tinega, Frances Crawford, Marc Giulianotti, Radleigh Santos, Gina M. Clayton, Yuxiao Wang, Xuewu Zhang, Lisa A. Maier, Philippa Marrack, John W. Kappler, Andrew P. Fontenot
Journal:
Journal of Experimental Medicine
J Exp Med (2013) 210 (7): 1403–1418.
Published: 24 June 2013
...Michael T. Falta; Clemencia Pinilla; Douglas G. Mack; Alex N. Tinega; Frances Crawford; Marc Giulianotti; Radleigh Santos; Gina M. Clayton; Yuxiao Wang; Xuewu Zhang; Lisa A. Maier; Philippa Marrack; John W. Kappler; Andrew P. Fontenot Chronic beryllium disease (CBD) is a granulomatous disorder...
Journal Articles
Journal:
Journal of Experimental Medicine
J Exp Med (1954) 99 (1): 43–53.
Published: 01 January 1954
Journal Articles
Journal:
Journal of Experimental Medicine
J Exp Med (1916) 23 (1): 15–24.
Published: 01 January 1916
Journal Articles
Journal Articles
Journal:
Journal of Experimental Medicine
J Exp Med (1953) 97 (4): 483–497.
Published: 01 April 1953
Journal Articles
Journal:
Journal of Experimental Medicine
J Exp Med (1990) 171 (4): 1123–1140.
Published: 01 April 1990
Journal Articles
Journal:
Journal of Experimental Medicine
J Exp Med (1955) 101 (2): 119–128.
Published: 01 February 1955
Images
in Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
> Journal of Experimental Medicine
Published: 14 May 2012
Figure 1. Suppression of inflammatory pain by CBD and DH-CBD in mice. (A) Time course of heat pain hypersensitivity in mice after 20 µl CFA paw injection (1:4 in saline). Each data point represents the mean from 10–15 mice. (B) The analgesic effect of i.p. (50 mg/kg, n = 10) and i.t More about this image found in Suppression of inflammatory pain by CBD and DH-CBD in mice. (A) Time cours...
Images
in Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
> Journal of Experimental Medicine
Published: 14 May 2012
Figure 5. Antagonism of DD-CBD to DH-CBD–induced potentiation of IGly and analgesia in inflammatory pain. (A) Structures of DH-CBD and DD-CBD. Trace records of IGly in HEK 293 cells expressing the α3 GlyRs without and with co-application of DD-CBD and DH-CBD. (B) DD-CBD More about this image found in Antagonism of DD-CBD to DH-CBD–induced potentiation of IGly and ...
Images
in Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
> Journal of Experimental Medicine
Published: 14 May 2012
Figure 6. A decrease in CBD and DH-CBD–induced analgesia in the α3−/− mice but not in the CB1−/− and CB2 −/− mice. (A and B) The analgesic effect of 50 mg/kg CBD i.p. (A) or 50 mg/kg DH-CBD i.p. (B) on PWL to thermal stimulation after CFA injection More about this image found in A decrease in CBD and DH-CBD–induced analgesia in the α3−/− mice...
Images
in Identification of beryllium-dependent peptides recognized by CD4+ T cells in chronic beryllium disease
> Journal of Experimental Medicine
Published: 24 June 2013
Figure 6. HLA-DP2–PLXNA4/Be tetramer staining of ex vivo BAL cells from CBD patients. (A) The binding kinetics of soluble AV22 TCR to biotinylated HLA-DP2–PLXNA4 with and without Be are shown. Four concentrations of soluble AV22 TCR were injected through the flow cells before and after loading More about this image found in HLA-DP2–PLXNA4/Be tetramer staining of ex vivo BAL cells from CBD patients....
Images
in Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
> Journal of Experimental Medicine
Published: 14 May 2012
Figure 2. DH-CBD potentiation of IGly in spinal neurons and suppression of inflammatory pain in rats. (A) Original recordings showing currents activated by puff application of 30 µM glycine to lamina II neurons with and without sustained DH-CBD application in rat spinal cord slices More about this image found in DH-CBD potentiation of IGly in spinal neurons and suppression of...
Images
in Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
> Journal of Experimental Medicine
Published: 14 May 2012
Figure 3. DH-CBD suppression of neuropathic pain in rats. (A) Time courses of the ipsilateral and contralateral PWT to mechanical stimulation after the fifth lumbar SNL in rats (n = 12). ***, P < 0.001, as compared with pre-SNL. (B and C) The analgesic effect of i.t. application More about this image found in DH-CBD suppression of neuropathic pain in rats. (A) Time courses of the ip...
Images
in Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
> Journal of Experimental Medicine
Published: 14 May 2012
Figure 4. DH-CBD rescue of PGE2-induced inhibition of the α3 GlyRs and chronic pain. (A) Trace records of IGly in HEK 293 cells coexpressing EP2 receptors with either the α3 or α1 GlyRs before and after sustained PGE2 application. (B) Time courses More about this image found in DH-CBD rescue of PGE2-induced inhibition of the α3 GlyRs and chr...
Images
in Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
> Journal of Experimental Medicine
Published: 14 May 2012
Figure 8. NMR analysis: a direct interaction between CBD and S296-containing domain of α3 GlyR. (A) A homology model of α3 GlyR-TM domain structure derived from the high-resolution NMR structure of α1 GlyR TM domains. S296 residue is highlighted in red. (B) Contour plots of the S296 resonance More about this image found in NMR analysis: a direct interaction between CBD and S296-containing domain o...
Images
in Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
> Journal of Experimental Medicine
Published: 14 May 2012
Figure 9. The effect of DH-CBD on α3 GlyR gating kinetics and agonist affinity. (A) Traces of currents activated by 1 mM glycine in HEK 293 cells expressing WT or S296A mutant α3 GlyRs in the absence and presence of 3 µM DH-CBD. Bar graph shows the mean activation time constant (n = 6 More about this image found in The effect of DH-CBD on α3 GlyR gating kinetics and agonist affinity. (A) ...
Images
in NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis
> Journal of Experimental Medicine
Published: 24 April 2006
Figure 7. Dilated CBD is an early and specific indication of NOD.c3c4 biliary disease and reflects lymphocytic infiltration. (a) Substantially dilated CBDs (CBD) compared with the portal vein (PV) are found only in NOD.c3c4 mice (left) with liver disease, but not in NOD mice (right) or any More about this image found in Dilated CBD is an early and specific indication of NOD.c3c4 biliary disease...
Journal Articles
In Special Collection:
Neurodegeneration and Neuroinflammation 2020
Sneha Narasimhan, Lakshmi Changolkar, Dawn M. Riddle, Alexandra Kats, Anna Stieber, Sarah A. Weitzman, Bin Zhang, Zhiyong Li, Erik D. Roberson, John Q. Trojanowski, Virginia M.Y. Lee
Journal:
Journal of Experimental Medicine
J Exp Med (2019) 217 (2): e20190783.
Published: 11 December 2019
... (AD), tau aggregates in neurons, while in corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP), tau also aggregates in astrocytes and oligodendrocytes. We previously demonstrated that human CBD and PSP tauopathy lysates (CBD-tau and PSP-tau) contain distinct tau strains...
Includes: Supplementary data
Journal Articles
Wei Xiong, Tanxing Cui, Kejun Cheng, Fei Yang, Shao-Rui Chen, Dan Willenbring, Yun Guan, Hui-Lin Pan, Ke Ren, Yan Xu, Li Zhang
Journal:
Journal of Experimental Medicine
J Exp Med (2012) 209 (6): 1121–1134.
Published: 14 May 2012
...Figure 1. Suppression of inflammatory pain by CBD and DH-CBD in mice. (A) Time course of heat pain hypersensitivity in mice after 20 µl CFA paw injection (1:4 in saline). Each data point represents the mean from 10–15 mice. (B) The analgesic effect of i.p. (50 mg/kg, n = 10) and i.t...
Includes: Supplementary data
Images
in Identification of beryllium-dependent peptides recognized by CD4+ T cells in chronic beryllium disease
> Journal of Experimental Medicine
Published: 24 June 2013
Figure 7. Distribution of plexin A proteins in antigen-presenting cells, BAL fluid, and lung tissue derived from CBD patients. (A) Western blot analysis of cell extracts from the mouse fibroblast cell lines (DP8302 and DP2.21) and EBV-transformed B cells from CBD patient 1332 and BAL fluid from More about this image found in Distribution of plexin A proteins in antigen-presenting cells, BAL fluid, a...
1











